Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/16/2002EP1248638A2 Novel therapeutic use of enoxaparin
10/16/2002EP1248635A1 Antisense modulation of glycogen synthase kinase 3 alpha expression
10/16/2002EP1248634A1 Antisense modulation of mekk2 expression
10/16/2002EP1248633A1 Antisense modulation of glycogen synthase kinase 3 beta expression
10/16/2002EP1248593A1 Treatment of uv induced immunosuppression
10/16/2002EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002EP1248516A2 38 human secreted proteins
10/16/2002EP1100528B1 Use of novel agents inducing cell death in synergy with interferons
10/16/2002EP1098660B1 Encapsulation of water soluble peptides
10/16/2002EP1037652B1 Pharmaceutical compositions based on dalfopristin and quinupristin and preparation
10/16/2002EP0941218B1 Antithrombotic organic nitrates
10/16/2002EP0941108B1 Wound healing and treatment of fibrosis
10/16/2002EP0914147B1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
10/16/2002EP0868429B1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/16/2002EP0846682B1 Penicillaminamide derivatives
10/16/2002EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002EP0774001B1 Production of tissue factor pathway inhibitor
10/16/2002EP0750669B1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
10/16/2002EP0728205B1 Reagent for treatment of arthritic conditions
10/16/2002EP0721343B1 Pharmaceutical formulations of nerve growth factor
10/16/2002EP0672128B1 Stem cell proliferation factor
10/16/2002EP0670847B1 Subtilin variant of enhanced stability and activity
10/16/2002EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002CN1375007A A gene encoding a novel threonyl-tRNA synthetase, its uses and the preparing methods
10/16/2002CN1375004A Methods and compsotions for inhibiting the function of polynucleotide sequences
10/16/2002CN1374969A FAP-activated anti-tumor compounds
10/16/2002CN1374871A FC fusion proteins for enhancing the immunogenicity of protein and piptide antigens
10/16/2002CN1374869A Use of CASB 616 polypeptides and polynucleotides for cancer treatment
10/16/2002CN1374858A For mulations for parenteral use of estramustine phosphate with improved pharmacological properties
10/16/2002CN1374320A HAb18G(/CD147) peptide agonist and its prepn and use
10/16/2002CN1374318A Natural dissociation essence gamma gene and antineoplastic active polypeptide dissociation essence-gamma
10/16/2002CN1374316A Macrocyclic target specific antisense nucleic acid compound
10/16/2002CN1374131A AIDS treating medicine Boke capsule and its prepn
10/16/2002CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/15/2002US6465627 DAX-1 protein, methods for production and use thereof
10/15/2002US6465624 Purification of von-Willebrand factor by cation exchanger chromatography
10/15/2002US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002US6465620 Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides
10/15/2002US6465617 Polypeptide encoded by cell death-protective gene from the nematode caenorhabditis elegans, called ced-9
10/15/2002US6465616 Modified and variant forms of interleukin-5 having specified amino acid subsitutions
10/15/2002US6465614 High-affinity response-selective C-terminal analogs of C5a anaphylatoxin
10/15/2002US6465613 Administering a somatostatin derivative to a patient for selectively targeting and arresting the growth of an angiogenic blood vessel or a cell
10/15/2002US6465612 Synthetic peptides, conjugation reagents and methods
10/15/2002US6465611 Compounds for immunotherapy of prostate cancer and methods for their use
10/15/2002US6465516 Increasing nitric oxide production by administering inhibitors of hmg-coa-reductase; treatment of diseases related to endothelial dysfunction
10/15/2002US6465471 Cinnamic acid derivatives
10/15/2002US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002US6465434 Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465431 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
10/15/2002US6465430 Treating hematological disorders, particularly thrombo-cytopenia resulting from chemotherapy, radiation therapy or bone marrow transfusions; accelerating blood platelet regeneration
10/15/2002US6465429 Antimicrobial cationic peptides
10/15/2002US6465427 Compounds and methods for modulating cell adhesion
10/15/2002US6465426 Acylation
10/15/2002US6465425 Biodegradable materials, such as polymers, encapsulating protein medicaments (such as beta-ifn) can be employed as a sustained delivery system
10/15/2002US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002US6465423 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/15/2002US6465422 Method for inhibiting tumor invasion or spreading in a subject
10/15/2002US6465421 Promoting the growth of body and/or head hair and/or combatting the loss of such hair via cyclooxygenase treatment, as well as, contrariwise, retarding and/or preventing the growth of body/cranial hair via lipoxygenase treatment
10/15/2002US6465253 Vectors and methods for gene transfer to cells
10/15/2002US6465250 Antisense modulation of protein phosphatase 2 catalytic subunit alpha expression
10/15/2002US6465246 Oncogene- or virus-controlled expression systems
10/15/2002US6465239 Genetically engineered chromosomes in germ cells; high protein and muscle foods
10/15/2002US6465232 Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor
10/15/2002US6465231 GSK3 polypeptides
10/15/2002US6465214 Antithrombin protein and DNA sequences from black fly
10/15/2002US6465213 Nucleotide sequences
10/15/2002US6465211 Nucleic acids, vectors and transformed cells for making and using high affinity IP-3 binding polypeptides
10/15/2002US6465198 Essential fungal genes and their use
10/15/2002US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002US6465184 Determining gene expression of nucleic acid encoding tumor rejection antigen precursors
10/15/2002US6465181 Reagents and methods useful for detecting diseases of the prostate
10/15/2002US6465173 Diagnosis, therapy aids
10/15/2002US6465001 Treating medical conditions by polymerizing macromers to form polymeric materials
10/15/2002US6464998 Composition for the in vivo production of therapeutic products
10/15/2002US6464994 Diaper dermatitis preventative medication and a method for making and using same
10/15/2002US6464987 Pharmaceutical compositions capable of being gelled
10/15/2002US6464986 Method for treating pain by peripheral administration of a neurotoxin
10/15/2002US6464985 Ospc dra fragment fusion peptide isolated from borrelia burgdorferi
10/15/2002US6464983 Methods and uses of connective tissue growth factor for differentiation of mesenchymal stem cells
10/15/2002US6464980 MAGE-1 c-terminal immunogenic peptides
10/15/2002US6464979 Chlamydial vaccines and methods of preparation thereof
10/15/2002US6464975 Heparin-binding glycoprotein-related peptide; facilitates angiogenesis or wound healing
10/15/2002US6464851 Appropriate membranes used and the cartridge housing the membrane configured to include separate chambers for the isolated bacteria and viruses; gradiflow electrophoresis
10/15/2002US6463933 Bone marrow as a site for transplantation
10/15/2002CA2277801C Preparation of particles for inhalation
10/15/2002CA2169173C Methods for stimulating erythropoiesis using thrombopoietin
10/15/2002CA2091873C Parathyroid hormone derivatives
10/15/2002CA2071912C Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
10/10/2002WO2002079515A1 Antisense modulation of urokinase plasminogen activator expression
10/10/2002WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002WO2002079474A2 Human b7 polypeptides
10/10/2002WO2002079473A2 Molecules for diagnostics and therapeutics
10/10/2002WO2002079464A2 Viral vectors
10/10/2002WO2002079462A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079459A2 Means for inhibiting proteolytical processing of parkin
10/10/2002WO2002079457A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
1 ... 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 ... 3163